ClinicalTrials.gg
Not yet recruitingNCT07054112MEDIAUpdated Jul 8, 2025

Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients

An interventional study of Mindfulness-Based Stress Reduction (MBSR) meditation program and Control group in Chronic Kidney Disease Requiring Hemodialysis, sponsored by University Hospital, Tours. Not yet recruiting at 10 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-08.

Sponsored by University Hospital, Tours · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 105 studies in Fatigue with a site in France — 34 open to participants now, 37 under way, 4 of them phase 3. Fatigue · France.

Planned enrollment
31st of 73
80 · median 70
Started
2025
with 17 others
No phase
61 of 105
23 open now
Primary completion
2026-11
later than 19 of 36 live
Registered
92nd of 105
by date

Among the 105 studies in Fatigue with a site in France, this one is the 31st largest by planned enrollment of the 73 interventional ones that give a count, is one of 18 that started in 2025, is one of 61 with no phase, reaches primary completion later than 19 of the 36 other live ones, and was the 92nd registered.

Fatigue

2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.

Browse Fatigue studies →

Open to participants now

34 of the 105 studies in Fatigue with a site in France are open now. Recruiting first, the newest first:

29 more — sign in →

All 34 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 105 studies in Fatigue with a site in France, or all of them as a file.
02

Study summary

The goal of this clinical trial is to assess the efficacy of a 2-month live online mindfulness meditation program in reducing perceived fatigue (measured by the SONG-HD Fatigue Scale) in patients undergoing chronic hemodialysis.

The sponsor expects that a live online mindfulness meditation course will have a significant public health impact by reducing perceived fatigue, which is strongly associated with cardiovascular events, mortality, and reduced quality of life.

Participants will be enrolled according to eligibility criteria and randomized into one of the following groups:

Experimental group: will receive an 8-week live online Mindfulness-Based Stress Reduction (MBSR) program.

Control group: will receive standard care during their hemodialysis sessions and will be offered the same live online MBSR program between months 8 and 10.

Patients will complete self-administered questionnaires at baseline, 2 months, 8 months, and 10 months to monitor changes in fatigue, anxiety, and quality of life.

Read the detailed description

Chronic kidney disease requiring a replacement therapy is a main public health issue. The overall incidence of treated end-stage renal disease is 169 per million inhabitants in France (Annual REIN report, Biomedicine Agency, 2021). Chronic kidney disease patients requiring a replacement therapy have a very increased mortality compared to the general population and their quality of life is particularly impacted.

The international initiative Standardized Outcomes in Nephrology hemodialysis (SONG-HD) has identified and prioritized the most important outcomes for patients requiring hemodialysis. The patients, their caregivers and health professionals have highlighted that perceived fatigue is one of the biggest issues once the hemodialysis began. Fatigue is a complex and subjective experience which include physical (muscular weakness, low stamina) and psychological symptoms (feeling of increased effort and decrease cognitive endurance). For patients with chronic hemodialysis, additionally to the burden of disease, they must receive in average three dialysis sessions per week which is a source of exhaustion. Fatigue is associated with an increase of cardiovascular events, an increase of mortality, a reduction of quality of life and consequently a less good compliance to dialysis. The outcome "fatigue" is then one of the critically important outcomes which must be assessed in all clinical trials and the investigators need to explore interventions to improve well-being of patients and to prevent patient's exhaustion.

Mindfulness meditation is defined as moment to moment self-regulation of attention. This practice helps cultivate non-judgmental acceptance of the present moment. Besides, a cognitive behavioral therapy including meditation significantly improve the well-being, the mood, the anxiety and stress perception of chronic hemodialysis patients. Several studies have showed that mindfulness meditation is associated with a decrease of systolic blood pressure, a decrease of depressive symptoms and an increase in self-compassion scores in hemodialysis patients.

Numerous studies have shown a significant improvement in fatigue thanks to a mindfulness meditation program in patients with lung cancer, breast cancer, in healthcare workers facing fatigue linked to empathic distress or even in volleyball athletes presenting moral fatigue linked to strong competition. However, to our knowledge, there is no study assessing the impact of a mindfulness meditation program on fatigue patients receiving chronic hemodialysis.

The investigators hypothesize that mindfulness meditation could regulate the psychological and physical perceived fatigue of hemodialysis patients. Meditation provides techniques allowing the participant to learn to step back from emotions, thoughts and experience in general. This is the decentring process. Furthermore, yoga, which is a part of the program, can help regulate the physical aspects of fatigue by leading to an increase in muscle mass and cardiac activity.

Benefit/ risk balance Non-invasive test. Very favorable benefit/risk balance, taking into account the demonstrated benefits in terms of stress and fatigue management of mindfulness meditation programs.

Absence of serious adverse effects reported under normal conditions while respecting the usual contraindications corresponding to the inclusion criteria.

A recent research showed that practicing mindfulness meditation is associated with transient distress and negative impacts at rates similar to other psychological treatments.

03

Conditions studied

  • Chronic Kidney Disease Requiring Hemodialysis

Browse trials for

Keywords

  • chronic kidney desease
  • MBSR program
  • fatigue
  • Song scale
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age >= 18 years old
  • Written obtained from the participant
  • Patients on chronic hemodialysis for more than 3 months
  • Participant affiliated to social security system
  • Internet access
  • Patient motivation/commitment
  • Patient having 3 days of dialysis per week

Exclusion criteria

Exclusion Criteria:

  • Major acute depression
  • Patient on peritoneal dialysis
  • Already participated in an MBSR program
  • Patients covered by articles L1121-5 to L1121-8 of the French Public Health Code (corresponding to protected persons: pregnant women, women who have recently given birth or are breastfeeding, persons deprived of their rights by judicial or administrative decision, minors, and persons benefiting from legal protection: curatorship or guardianship).
  • Planned hospitalization within 4 months
  • Known cognitive disorder (Mini Mental State Evaluation \<23 for more than 65 years)
  • Known schizophrenia
  • Known psychotic personality disorder
  • Suicide attempt or suicidal ideation
  • Addiction to alcohol or drugs during addiction treatment
  • Cancer undergoing chemotherapy
  • Pathological grieving process
  • Compulsive eating disorders
  • No understanding of French
  • Unaided deafness
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Experimental group

    Patients receive an MBSR (Mindfulness on Stress Reduction) meditation program delivered by a certified instructor.

    Other: Mindfulness-Based Stress Reduction (MBSR) meditation program

  • Other
    Control group

    Patients will be in a wait list group. They will receive their usual care during the study follow-up. Between M8 and M10 they will receive a MBSR meditation program

    Other: Control group

Interventions

  • OtherMindfulness-Based Stress Reduction (MBSR) meditation program

    The sessions of the meditation program (Mindfulness on Stress Reduction) will be delivered online, outside of the dialysis sessions. They will receive standard care during their hemodialysis sessions. The program is composed of 8 sessions of 2h30 + 1 day of mindfulness, during 2 months.

  • OtherControl group

    Patients in the control group will be in a wait list group. They will receive standard care during their hemodialysis sessions. they will receive the MBSR meditation program between M8 and M10.

06

What researchers measure

Primary outcomes

  1. Change in the SONG-HD fatigue scale between baseline and 2 months follow-up.

    SONG-HD scale means Standardised Outcomes in Nephrology-Haemodialysis; The score will vary from 0 to a maximum of 9

    Time frame: Between baseline and 2 months follow-up.

Secondary outcomes

  1. Evolution of the score on the SONG-Fatigue scale between baseline, M2, M8 and M10

    SONG-HD scale means Standardised Outcomes in Nephrology-Haemodialysis; The score will vary from 0 to a maximum of 9

    Time frame: between baseline, Month-2, Month-8 and Month-10

  2. Evolution of MFI score between baseline, M2, M8

    MFI means Multidimensional Fatigue Inventory. The score will vary from 0 to a maximum of 100

    Time frame: between baseline, Month-2, Month-8

  3. Evolution of quality of life (KDQOL) at baseline, M2, M8

    KDQOL means Kidney Disease Quality of Life

    Time frame: at baseline, Month-2, Month-8

  4. Evolution of anxiety (HAD) between baseline, M2, M8

    HAD means Hospital Anxiety and Depression scale. The HAD scale is a screening instrument for anxiety and depressive disorders. It comprises 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven to depression (total D), giving two scores (maximum score for each = 21).

    Time frame: between baseline, Month-2, Month-8

  5. Evolution of Mindfulness Score (FFMQ) between baseline, M2 and M8

    FFMQ means Five Facet Mindfulness Questionnaire. It comprises 39 questions. Each item ranges from 1 to 5.

    Time frame: between baseline, Month-2 and Month-8

  6. The occurrence of cardiovascular events at M8

    Time frame: at Month-8

  7. Mortality at M8

    Time frame: At Month-8

  8. The number of vascular access events at M8

    Time frame: At Month-8

07

Study locations

10 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2025; primary completion for Nov 2026, 14 months later.

Of 937 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 14 months is above that.

Counting every sponsor, half of 990 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2025
First posted
Jul 8, 2025
StartEst.
Sep 30, 2025
Primary completionEst.
Nov 30, 2026
CompletionEst.
Jul 30, 2027
Last update
Jul 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07054112
Responsible party
Sponsor
First posted
Jul 8, 2025
Start date
Sep 30, 2025 (estimated)
Primary completion
Nov 30, 2026 (estimated)
Completion
Jul 30, 2027 (estimated)
Last update
Jul 8, 2025

Study contacts

Marine NAUDIN, PhD
Contact
m.naudin@chu-tours.fr
+33 2.47.47.91.23
Bénédicte Sautenet, PU-PH
Contact
benedicte.sautenet@univ-tours.fr
+33 2 47 47 02 80
Marine NAUDIN, PhD
principal investigator · CHRU de Tours

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion